Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LINC00506 (long intergenic non-protein coding RNA 506) is a long non-coding RNA (lncRNA) classified as a long intergenic non-coding RNA (lincRNA), meaning it is a transcript longer than 200 nucleotides that does not overlap any known protein-coding genes and does not encode a protein[1][3][5]. LINC00506 is annotated in databases such as NCBI Gene (ID: 100846978) and Ensembl (ENSG00000281392)[1]. The specific biological functions and mechanisms of action of LINC00506 have not been extensively characterized in the scientific literature as of September 2025. However, lincRNAs as a class are recognized for their roles in regulating gene expression at multiple levels, often impacting chromatin state, transcriptional and post-transcriptional processes, and interacting with other nucleic acids and proteins[3][5]. While related long non-coding RNAs have established roles in cancer and other diseases, there is insufficient evidence to link LINC00506 directly to specific biological functions or disease mechanisms at this time[1][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 506 (LINC00506).